Pay to Marwadi

Company Profile

SYNGENE INTERNATIONAL LTD.

NSE : SYNGENEBSE : 539268ISIN CODE : INE398R01022Industry : Business SupportHouse : Private
BSE677.95-9.45 (-1.37 % )
PREV CLOSE (Rs.) 687.40
OPEN PRICE (Rs.) 697.80
BID PRICE (QTY) 677.40 (20 )
OFFER PRICE (QTY) 677.95 (1 )
VOLUME 27892
TODAY'S LOW / HIGH (Rs.)674.30 697.80
52 WK LOW / HIGH (Rs.)660.35 860.2
NSE677.80 -9.45 (-1.38 % )
PREV CLOSE(Rs.) 687.25
OPEN PRICE (Rs.) 694.10
BID PRICE (QTY) 677.55 (2 )
OFFER PRICE (QTY) 677.90 (34 )
VOLUME 495434
TODAY'S LOW / HIGH(Rs.) 674.30 698.00
52 WK LOW / HIGH (Rs.)660.35 860.25

Company Profile

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Trade Value (Rs. in Lacs) 0.00
Dividend Yield(%) 0.18
TTM EPS (Rs.) 11.59
P/E Ratio 58.23
Book Value (Rs.) 104.14
Face Value (Rs.) 10
MCap (Rs. in Mn) 271652.08
Price/Earning (TTM) 32.52
Price/Sales (TTM) 8.48
Price/Book (MRQ) 6.48
PAT Margin (%) 14.81
ROCE (%) 15.61
Incorporation Year : 1993

Management Info :

Kiran Mazumdar Shaw - Chairman Jonathan Hunt - Managing Director

Registered Office :

Address : Biocon Sez, Biocon Park, No 2 & 3, Bommasandra,Industrail Area, Iv Pahse,Jigani Link Rd,
Bengaluru,
Karnataka-560099

Phone : 080 6891 8000

Registrar's Details : K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE
NEWS More
24Apr04-24-2024$ Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS Announcement under Regulati
Allotment of shares under Syngene Restricted Stock Units Long Term Incentive Plan FY 2020.
Allotment of shares under Syngene Restricted Stock Units Long T..
30Mar03-30-2024$Syngene International informs about disclosure Syngene International inform

Pursuant to Regulation 30(4) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Syngene International has informed that the Company has received an assessment order passed by the Income Tax Department for Assessment Year 2022-23. The details as required under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended) are enclosed. The above information will also be made available on the Company’s website at: www.syngeneintl.com.

The above information is a part of company’s filings submitted to BSE.
Pursuant to Regulation 30(4) of the SEBI (Listing Obligations a..
21Feb02-21-2024$Syngene International informs about analyst meet Syngene International inform

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Syngene International has informed about meeting with the Analyst/ Institutional Investor ‘Schroders plc’ held on 26.02.2024 at 10:00 am in Bengaluru. The above-mentioned information will also be made available on the website of the Company www.syngeneintl.com. 

The above information is a part of company’s filings submitted to BSE.

Pursuant to Regulation 30 of the SEBI (Listing Obligations and..
23Dec12-23-2023$Syngene International informs about update Syngene International inform

Syngene International has informed about update on the acquisition of biologics manufacturing facility from Stelis Biopharma. 

The above information is a part of company’s filings submitted to BSE.

Syngene International has informed about update on the acquisit..
14Dec12-14-2023$Syngene International informs about analyst meet Syngene International inform
Syngene International has informed that it enclosed the details of the cancelled Analyst/Institutional Investor Meeting scheduled for December 21, 2023.

The above information is a part of company’s filings submitted to BSE.
Syngene International has informed that it enclosed the details..
Financials More
Rs. in Millions
QTR Mar 24 ANNUAL 24
Net Profit18984665
Gross Profit 2104 5573
Operating Profit 31469668
Net Sales 864732031
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group More
Krystal Integrated (BSE)
 754.05 (3.26%)
M.Cap ( in Cr)
1061.66
Swadeshi Polytex (BSE)
 267.10 (4.99%)
M.Cap ( in Cr)
1041.69
Techknowgreen Solutn (BSE)
 237.20 (5.42%)
M.Cap ( in Cr)
173.49
Medi Assist Health (BSE)
 512.15 (1.09%)
M.Cap ( in Cr)
3592.26
Vanta Bioscience (BSE)
 75.20 (4.94%)
M.Cap ( in Cr)
47.47
Shareholding Pattern More
NON-INSTITUTION 8.49 %
PROMOTERS 54.79 %
MUTUAL FUNDS/UTI 12.59 %
FI/BANKS/INSURANCE 1.71 %
GOVERNMENT 0 %
FII 0 %
MF HOLDINGS More
F & O Quotes